FOS Capital Ltd Q1 Trading Update
Key points
- Sales of $7.25m, up 64% year-over-year
- EBITDA $0.55m, significantly improved
- Order book at $10.5m, up 15% year-over-year
- Active quote pipeline of $130m
Full summary
FOS Capital Ltd reported an impressive first quarter of FY27, achieving unaudited sales of $7.25 million, a 64% increase year-over-year, and EBITDA of $0.55 million, significantly improving from the previous period. The order book stood at $10.5 million, up 15% year-over-year, while the active quote pipeline remained robust at approximately $130 million. The company secured significant project wins, including the Monash Medical Clinic project and the Queensland Schools Lighting Upgrade Program. FOS also successfully completed a $1.82 million capital raise. The company expects trading momentum to continue into Q227, supported by a strong order book and quote pipeline.
Guidance
Sales volumes for Q227 expected to be similar to Q127
Outlook
FOS expects trading momentum to continue into Q227, supported by a strong order book and quote pipeline, along with the ongoing benefits of the cost reduction program.
Summary generated by a large language model. Please interpret with care.